Generation of a Surgical Field in the Left Lateral Decubitus Position

Sponsor
Shizuoka Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT04683601
Collaborator
(none)
154
56

Study Details

Study Description

Brief Summary

The generation of a good surgical field at the mid-lower mediastinum during thoracoscopic esophagectomy in the left lateral decubitus position is often complicated. The investigators developed a simple and useful technique for surgical field generation.

Condition or Disease Intervention/Treatment Phase
  • Other: Thoracoscopic esophagectomy in left decubitus

Study Design

Study Type:
Observational
Actual Enrollment :
154 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Generation of a Surgical Field at the Mid-lower Mediastinum for Thoracoscopic Esophagectomy in the Left Lateral Decubitus Position
Actual Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Dec 1, 2019
Actual Study Completion Date :
Dec 1, 2019

Outcome Measures

Primary Outcome Measures

  1. Completion rate of thoracoscopic esophagectomy [During surgery]

    The rate of completion of thoracic esophagectomy with our method for the generation of surgical field in mid-lower mediastinum.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who underwent thoracoscopic esophageal resection from April 2015 to December 2019 in our hospital.
Exclusion Criteria:
  • patients who underwent open thoracotomy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Shizuoka Cancer Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kenjiro Ishii, Principal Investigator, Shizuoka Cancer Center
ClinicalTrials.gov Identifier:
NCT04683601
Other Study ID Numbers:
  • ShizuokaCC 2
First Posted:
Dec 24, 2020
Last Update Posted:
Dec 24, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kenjiro Ishii, Principal Investigator, Shizuoka Cancer Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 24, 2020